Tube Pharmaceuticals

The core assets of Tube Pharmaceuticals GmbH are natural product categories and their synthetic analogs, including product platforms with a variety of collaboration and development opportunities. These compound classes demonstrate a highly effective spectrum of biological activity against tubulin and are primarily used in new oncology treatment methods. In particular, the ability to conjugate highly active compounds with any type of delivery technology or targeting principle provides powerful development opportunities for more effective and safer products.